Malaria vaccine co-developed by Serum Institute will bridge supply gap: Adar Poonawalla

The WHO has recommended the use of a malaria vaccine developed by the University of Oxford and the Serum Institute of India (SII). The vaccine, known as R21/Matrix-M, has shown good safety and high efficacy in clinical trials in four countries. The SII expects that the vaccine could be ready for wider roll-out as early as next year, pending additional regulatory approvals.